| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
Why this is the main focus:
Enhanced diagnostic accuracy: AI algorithms rapidly analyze X-rays, CTs, MRIs, and ultrasounds, identifying subtle abnormalities that human eyes can miss—such as early-stage cancers, nodules, or fractures—leading to more reliable diagnoses
Faster image interpretation: AI automates the review process, prioritizing urgent cases (e.g. stroke or hemorrhage detection) and enabling quicker clinical decision-making, which improves patient outcomes
Improved workflow efficiency: By assisting with report drafting and reducing radiologist burden, AI contributes to faster turnaround times and more consistent diagnostic standards
Support for personalized treatment: Integrating imaging analysis with other patient data allows AI to aid in risk prediction and tailored treatments in areas like oncology and cardiology
Conclusion: The core aim of AI in medical imaging is to augment diagnostic precision and speed, enabling earlier interventions and ultimately enhancing patient care.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
A key benefit of AI in radiology, as highlighted in the article, is that it acts as a second medical opinion—providing an additional layer of review to support radiologists in interpreting scans.
Several sources support this:
Studies show AI tools are often used as a “second set of eyes,” flagging subtle anomalies that might otherwise be missed
Clinical research describes AI as a “second opinion,” helping radiologists resolve ambiguous cases and reducing stress in decision-making
In practical healthcare settings, radiologists combine their own interpretation with AI feedback—like saying, “I looked at it, and the computer looked at it, and we both agree”—to enhance patient confidence
Conclusion: The standout advantage of AI in radiology, according to the article, is that it acts as a second medical opinion, enhancing diagnostic accuracy and reinforcing clinicians' trust in their decisions.
Conclusion: The standout advantage of AI in radiology, according to the article, is that it acts as a second medical opinion, enhancing diagnostic accuracy and reinforcing clinicians' trust in their decisions.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
According to the article, AI literacy refers to understanding and knowledge of AI technology—specifically, the skills and awareness needed to effectively deploy and engage with AI systems while being mindful of their opportunities, risks, and implications
Why that’s the right answer
The European AI Act defines “AI literacy” as “skills, knowledge and understanding that allows providers, deployers and affected persons … to make an informed deployment of AI systems, as well as to gain awareness about the opportunities and risks of AI and possible harm it can cause”
The emphasis isn’t on mechanical or legal expertise, but on conceptual literacy: gaining a foundational grasp of AI—what it is, how it works, what it can do—and understanding its impact.
In summary: AI literacy means knowing + understanding AI—how to use it wisely, recognize its strengths and limitations, and be aware of its risks and ethical implications.
ที่มา
ถาม ChatGPT
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The other factors listed in your options—trust in AI systems, integration with existing workflows, system understanding, and technology receptiveness—are all explicitly cited as important influences on whether healthcare professionals accept and adopt AI . |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Influences AI's diagnostic accuracy |
|
Why that's the correct answer:
In studies on AI acceptance using models like UTAUT (Unified Theory of Acceptance and Use of Technology), social influence is defined as the degree to which an individual perceives that important others think they should use the system—significantly impacting their behavioral intention to do so
Research in nursing found that various forms of social influence—such as conformity and encouragement from peers—influenced nurses’ intentions to adopt AI-based systems .
Bottom line: In healthcare, social influence refers to how the attitudes and approvals of peers, leaders, and professional networks sway clinicians toward adopting AI solutions. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
Why this is a key perceived threat:
In a survey of nurses, many feared AI might replace human roles and lead to more impersonal care:
“AI threatens our jobs and makes care even more impersonal.”
A study involving medical professionals showed one-third of respondents saw AI as threatening to professional recognition, autonomy, and expertise:
“participants feared that physicians might become redundant and reduced to a mere voice of the AI system.” |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
Why this is the correct choice
A comprehensive scoping review found that boosting acceptance of AI among healthcare providers requires more than just top-tier algorithms—it demands human‑centered design that considers:
Accessibility for users with varying AI literacy
Integration into clinical workflows and institutional contexts
Alignment with cultural, ethical, and safety norms of healthcare professions This means the emphasis is on user-friendly, intuitive systems created with input from healthcare professionals—not just powerful AI with high algorithmic performance. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
The 'system usage' category of AI acceptability factors—according to the article—includes factors like value proposition and integration with workflows, among others such as self‑efficacy and burden:
Value proposition: How much healthcare professionals view AI as providing meaningful benefits, like improving productivity or diagnostic accuracy.
Burden: The perceived effort required to use AI in daily practice relative to existing workflows.
Self‑efficacy: Professionals' confidence in their ability to use AI (e.g. understanding and applying its outputs).
Workflow integration: The extent to which AI fits smoothly into existing clinical workflows and procedures
In summary: The 'system usage' domain covers practical and operational aspects like whether AI provides value, can be used easily, fits into workflows, and is supported by users’ confidence in using it. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Why that’s correct
According to the scoping review, ethicality—grouped under socio‑organisational‑cultural factors—is a critical influence on whether clinicians accept AI toolsIt reflects concerns about:
Fairness & equity (e.g., ensuring AI doesn't worsen disparities)
Transparency, patient autonomy, privacy, accountabilityInstitutional fit with the moral norms and duties of medical professionals
When AI systems are perceived as compatible with professional values such as autonomy, non‑maleficence, and justice, their acceptance increases.In summary: Ethicality shapes clinicians’ acceptance of AI by influencing whether they see it as morally aligned with their professional values and ethical obligations—not by affecting pricing, manufacturing, or legality only.
In summary: Ethicality shapes clinicians’ acceptance of AI by influencing whether they see it as morally aligned with their professional values and ethical obligations—not by affecting pricing, manufacturing, or legality only. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Why this is the correct approach
This oversight is often due to the use of theoretical frameworks and ad-hoc approaches that are not designed to capture the complexities of AI deployment in healthcare settings.of the causal importance of different factors in achieving high medical AI acceptance. While cost is an important consideration, it does not encompass the multifaceted aspects of AI acceptability, such as user experience and system integration.This approach could compromise patient safety and trust in AI systems, which are critical for their acceptance.
Designinghuman-centred AI systems Limiting AI use to large hospitals may not address the broader challenges of AI integration across diverse healthcare settings.As demonstrated, the emphasis should be on considering user experience and system integration deeply.
synthesising evidence For AI to be effectively accepted and integrated into healthcare, future studies must adopt a methodological approach that prioritises user experience and seamless system integration, ensuring that AI tools align with the needs and practices of healthcare professionals |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Why Replacing Dopamine Neurons Is Crucial
Ensuring that transplanted hESCs do not form tumors is a critical concern. Advances in differentiating hESCs into mature dopaminergic neurons before transplantation aim to mitigate this risk.The use of hESCs may lead to immune rejection. Strategies such as immunosuppressive therapies and the development of patient-specific induced pluripotent stem cells (iPSCs) are being explored to address this issue.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Rats |
|
This Good Laboratory Practice (GLP)-compliant study assessed toxicity, tumorigenicity, and biodistribution, with results indicating no adverse effects.
A first-in-human Phase I/IIa clinical trial has been initiated in Sweden, involving 8 patients with moderate Parkinson’s disease While rats were primarily used in the preclinical safety and efficacy studies, other animal models, including non-human primates, have been utilized in stem cell research for Parkinson’s disease. For example, previous studies have involved transplanting stem cells into monkeys with Parkinson’s-like symptoms to assess therapeutic potential |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
9 months |
|
The duration of the preclinical safety study in rats mentioned in the article was 9 months (39 weeks). |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
The trial for STEM-PD is labeled Phase I/IIa because it combines aspects of both early-phase clinical trials:
Phase I focuses on safety — making sure the treatment is safe for humans, determining safe dosage levels, and identifying any side effects.
Phase IIa explores early evidence of efficacy — it looks at whether the treatment starts to show signs of working in patients, but still involves a small number of participants.
By combining Phase I and IIa, the trial can efficiently evaluate both safety and preliminary effectiveness in one study, especially important for novel treatments like stem cell therapies. This approach helps accelerate development while ensuring patient safety. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
STEM-PD is manufactured under GMP-compliant conditions because:
GMP (Good Manufacturing Practice) ensures that products are consistently produced and controlled to quality standards appropriate for their intended use.
For clinical-grade stem cell therapies like STEM-PD, GMP compliance is essential to guarantee safety, purity, potency, and reproducibility.
This compliance is required by regulatory agencies (like the FDA or EMA) before a product can be tested in humans, ensuring that manufacturing processes minimize risks such as contamination or variability.
GMP manufacturing supports regulatory approval and builds trust in the product’s quality for clinical trials and future treatments.
In short, GMP compliance is crucial for translating stem cell products from the lab bench to safe and effective therapies for patients. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
The safety of STEM-PD was confirmed because:
No adverse effects means the treated rats did not experience harmful reactions or toxicity from the stem cell therapy.
No tumor formation is especially important since stem cells can sometimes form tumors if undifferentiated cells remain or if there is uncontrolled growth.
Absence of these issues in the 9-month preclinical safety study showed that the product was safe for further development and clinical testing.
This confirmation builds confidence that the therapy won’t cause serious side effects in humans, which is a critical step before starting human trials.
So, the lack of adverse effects and tumors is a strong indicator of the product’s safety profile. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells increased cognitive impairments. |
|
This finding is important because:
Parkinson’s disease primarily causes motor deficits due to the loss of dopamine-producing neurons.
The transplanted STEM-PD cells are designed to replace those lost neurons and restore dopamine production.
Reversal of motor deficits in rats shows that the transplanted cells survived, integrated into the brain, and functioned properly to improve movement.
This provides strong preclinical evidence that the therapy could be effective in treating Parkinson’s symptoms in humans.
Demonstrating functional recovery in animal models is a key milestone before moving to human clinical trials.
So, the reversal of motor deficits indicates that STEM-PD is doing what it’s intended to do—help restore motor function by replacing lost neurons. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
GIRK2 and ALDH1A1 are used to assess the purity of the STEM-PD batch because:
They are specific markers of mature dopaminergic neurons, the cell type STEM-PD aims to produce for Parkinson’s treatment.
GIRK2 (G-protein-coupled inwardly-rectifying potassium channel 2) is associated with the functional subtype of dopaminergic neurons found in the substantia nigra, the region affected in Parkinson’s.
ALDH1A1 (Aldehyde dehydrogenase 1 family member A1) is another marker expressed in these neurons and linked to their dopamine-producing capacity.
High expression of these markers indicates that the stem cells have successfully differentiated into the target neuron type and that the batch is pure, reducing risks of undifferentiated or unwanted cells.
Ensuring purity with these markers helps confirm the product’s efficacy and safety before clinical use.
So, GIRK2 and ALDH1A1 are crucial to verify that STEM-PD contains the right, functional neuron types for therapy.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
FGF8b (Fibroblast Growth Factor 8b) and SHH (Sonic Hedgehog) play a crucial role because:
During normal brain development, these growth factors provide positional and patterning signals that instruct stem cells where and how to differentiate.
SHH helps specify ventral neural identities, which is important because dopaminergic neurons in Parkinson’s disease come from the ventral midbrain.
FGF8b works alongside SHH to refine the regional identity and promote the development of midbrain dopaminergic neurons.
By adding these factors in the lab, manufacturers mimic natural developmental cues, ensuring stem cells differentiate into the correct neuron subtype (dopaminergic neurons).
This precise patterning is essential for producing effective and functional cells for therapy, improving both purity and safety.
So, FGF8b and SHH guide the stem cells toward the right fate, which is key to making a successful stem cell product like STEM-PD.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
Recovery of motor function was the key outcome because:
Parkinson’s disease primarily causes motor symptoms due to loss of dopamine neurons.
The goal of STEM-PD is to restore these neurons and improve motor abilities.
Measuring motor function recovery in rats directly shows whether the transplanted cells are working as intended.
Improvement in motor skills indicates that the cells survived, integrated, and produced dopamine effectively.
This functional evidence is crucial before advancing to human trials, demonstrating real therapeutic potential.
So, motor recovery is the most relevant and meaningful measure of efficacy for a Parkinson’s therapy.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|